IntelliCell have received U.S. Patent allowance for its ultrasonic cavitation method

On January 17, 2013 the Company IntelliCell BioSciences, Inc. ("Company") (SVFC) announced that have received a notice of allowance regarding its U.S. Patent Application Serial No. 13/323,030 entitled "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells."

The allowed claims apply to IntelliCell's proprietary method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation. This technology comprises an innovative mechanical method for the separation of stromal vascular fraction without the use of enzymes. The innovative mechanical method of Ultrasonic cavitation is method of separating SVFCs from fat tissue. Vascular cells derived by this method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures.